Reduced Urinary Opioid Levels from Pain Management Patients Associated with Marijuana Use

References

• Dahlhamer J , LucasJ , ZelayaCet.al Prevalence of chronic pain and high-impact chronic pain among adults – United States 2016. MMWR Morb. Mortal. Wkly Rep.67, 1001–1006 (2018).
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration . Key substance use and mental health indicators in the United States: Results from the 2017 national survey on drug use and Health (2018). www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf/
   Google Scholar
• Scholl L , SethP , KariisaM , WilsonN , BaldwinG. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb. Mortal Wkly Rep.67, 1419–427 (2019).
   Web of Science ®Google Scholar
• Morgan JR , SchackmanBR , LeffJA , LinasBP , WalleyAY. Injectable naltrexone oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J. Subst. Abuse Treat.85, 90–96 (2018).
   PubMed Web of Science ®Google Scholar
• Lucas P . Rationale for cannabis-based interventions in the opioid overdose crisis. Harm. Red. J.14, 58–63 (2017).
   PubMed Web of Science ®Google Scholar
• Wen H , HockenberryJM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Int. Med.178(5), 673–679 (2018).
   PubMed Web of Science ®Google Scholar
• Shi Y , LiangD , BaoY , AnR , WallaceMS , GrantI. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug Alcohol Depend.194, 13–19 (2019).
   PubMed Web of Science ®Google Scholar
• Powell D , PaculaRL , JacobsonM. Do medical marijuana laws reduce addictions and deaths related to pain killers?J. Health Econ.58, 29–42 (2018).
   PubMed Web of Science ®Google Scholar
• Kim JH , Santaella-TenorioJ , MauroCet.al State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. AJPH Res.106(11), 2032–2037 (2016).
   PubMed Web of Science ®Google Scholar
• Bachhuber MA , SalonerB , CunninghamCO , BarryCL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med.174(10), 1668–1673 (2014).
   PubMed Web of Science ®Google Scholar
• Narang S , GibsonD , WasanADet.al Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J. Pain.9(3), 254–264 (2008).
   PubMed Web of Science ®Google Scholar
• Cooper ZD , BediG , RameshD , BalterR , ComerSD , HaneyM. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology43(10), 2046–2055 (2018).
   PubMed Web of Science ®Google Scholar
• Abrams DI , CoueyP , ShadeSB , KellyME , BenowitzNL. Cannabinoid–opioid interaction in chronic pain. Nature90(6), 844–851 (2011).
   Google Scholar
• Boehnke KF , LitinasE , ClauwDJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J. Pain17(6), 739–744 (2016).
   PubMed Web of Science ®Google Scholar
• Lucas P , BaronEP , JikomesN. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm. Reduction J.16, 9–19 (2019).
   PubMed Web of Science ®Google Scholar
• Reiman A , WeltyM , SolomonP. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res.2, 160–166 (2017).
   PubMedGoogle Scholar
• Degenhardt L , LintzerisN , CampbellGet.al Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the pain and opioids IN treatment (POINT) study. Drug Alcohol Depend.147, 144–150 (2015).
   PubMed Web of Science ®Google Scholar
• Nugent SM , YarboroughBJ , SmithNXet.al Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. Gen. Hosp. Psych.50, 104–110 (2018).
   PubMed Web of Science ®Google Scholar
• DiBenedetto DJ , WeedVF , WawrzyniakKMet.al The association between cannabis use and aberrant behaviors during chronic opioid therapy for chronic pain. Pain Med.19, 1997–2008 (2018).
   PubMed Web of Science ®Google Scholar
• Olfson M , WallMM , LiuS , BlancoC. Cannabis use and risk of prescription opioid use disorder in the United States. Am. J. Psych.175(1), 47–53 (2018).
   PubMed Web of Science ®Google Scholar
• Epstein DH , PrestonKL. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper. Am. J. Add.24, 323–328 (2015).
   PubMed Web of Science ®Google Scholar
• Bisaga A , SullivanMA , GlassAet.al The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug Alcohol Depend.154, 38–45 (2015).
   PubMed Web of Science ®Google Scholar
• Socías ME , WoodE , LakeSet.al High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis. Addiction113, 2250–2258 (2018).
   PubMed Web of Science ®Google Scholar
• Lindgren BW , McElrathGW , BerryDA. Introduction to Probability and Statistics.MacMillan, NY, USA,205 (1978).
   Google Scholar
• Baron EP , LucasP , EadesJ , HogueO. Patterns of medicinal cannabis use, strain, analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J. Headache Pain19(1), 37–64 (2018).
   PubMedGoogle Scholar
• Scavone JL , SterlingRC , WeinsteinSP , Van BockstaeleEJ. Impact of cannabis use during stabilization on methadone maintenance treatment. Am. J. Addict.22(4), 344–351 (2013).
   PubMed Web of Science ®Google Scholar